To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)
- Investigator
- Torge Rempe
- Status
- Accepting Candidates
- Ages
- 18 Years - 55 Years
- Sexes
- All
About me
I am an assistant professor with the department of neurology at the University of Florida College of Medicine. Additionally, I am the William T. and Janice M. Neely professor for research in multiple sclerosis. I attended medical school at the Christian-Albrecht University of Kiel in Germany, with one year spent at the University of Murcia in Spain. I graduated with my medical degree in 2012, then pursued my postgraduate neurology training in Germany at the University Hospital of Schleswig-Holstein.
After my preliminary year at SUNY Downstate Medical Center in New York, I completed my neurology residency at the University of Florida. The following year, I finished my clinical neuroimmunology fellowship at the University of California San Diego.
I am board-certified in neurology by the American Board of Psychiatry and Neurology, and I am licensed to practice medicine in both Florida and California. My clinical and research interests include multiple sclerosis, neurosarcoidosis, neuroimmunology, neuromyelitis optica, MOG antibody disease and autoimmune encephalitis. I have contributed to many publications, as well as speak German, English and Spanish.
My locations
Active clinical trials
The main objective of the study is to evaluate the efficacy of satralizumab compared with placebo based on time from randomization to the first occurrence of an adjudicated MOGAD relapse in the double-blind (DB) treatment period
- Investigator
- Torge Rempe
- Status
- Accepting Candidates
- Ages
- 12 Years - N/A
- Sexes
- All
Primary Objective: To determine the efficacy of SAR442168 compared to placebo in delaying disability progression in primary progressive multiple sclerosis (PPMS) Secondary Objectives: To evaluate efficacy of SAR442168 compared to placebo on clinical…
- Investigator
- Torge Rempe
- Status
- Accepting Candidates
- Ages
- 18 Years - 55 Years
- Sexes
- All
My research
Top areas of exploration
- Aquaporin 4 , 3 publications
- Neuromyelitis Optica , 3 publications
- Autoantibodies , 3 publications
- Disease Progression , 2 publications
Research activity
Search our accepted insurances list
Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.